Let us understand the important aspects related to the Amanta Healthcare IPO. First, let us see the basics about Amanta Healthcare:
Founded in 1994, Amanta Healthcare specialises in manufacturing sterile liquid pharmaceuticals, including large- and small-volume parenterals (LVPs & SVPs), IV fluids, ophthalmic solutions, respiratory care items, irrigation solutions, and medical devices. It employs advanced Aseptic Blow-Fill-Seal (ABFS) and ISBM technologies.
The company operates a WHO-GMP certified facility in Hariyala (Kheda, Gujarat) with multiple manufacturing lines, distributing products across 19 countries and supported by a robust domestic network of distributors and stockists.
Amanta Healthcare IPO Details 2025
The following are some of the important financial details of Amanta Healthcare IPO:
Detail
Value
IPO Open Date
September 1, 2025
IPO Close Date
September 3, 2025
Face Value
₹10 per share
IPO Price Band
₹120 to ₹126 per share
Issue Size
Approx ₹126 crore (fresh issue)
Fresh Issue
Entirely fresh issue (approx ₹126 cr)
Offer for Sale
–
Issue Type
Book Built Issue
IPO Listing
BSE & NSE
Retail Quota
Not more than 35%
QIB Quota
Not more than 50%
NII Quota
Not more than 15%
Amanta Healthcare IPO Market Lot
The following table provides information about the Amanta Healthcare IPO market lot:
Category
Lot Size
Shares
Amount (₹)
Retail Minimum
1
119
₹14,994
Retail Maximum
13
1,547
₹1,94,922
S-HNI Minimum
14
1,666
₹2,09,916
B-HNI Minimum
67
7,973
₹10,04,598
Amanta Healthcare IPO Dates
The following are the important dates related to Amanta Healthcare IPO:
Event
Date
IPO Open Date
September 1, 2025
IPO Close Date
September 3, 2025
Allotment Date
September 4, 2025
Refunds Initiation
September 5, 2025
Credit to Demat Account
September 5, 2025
IPO Listing Date
September 8, 2025
Amanta Healthcare Financial Report
The following table shows the financial report of Amanta Healthcare Ltd (in ₹ crore):
Fiscal Year
Revenue (₹ crore)
Profit After Tax (₹ crore)
FY2024
₹281.61
₹3.63
FY2025
₹276.09
₹10.50
Promoters of Amanta Healthcare IPO
They are:
Bhavesh Patel,
Vishal Patel,
Jayshreeben Patel,
Jitendrakumar Patel,
Milcent Appliances Pvt. Ltd.
Lead Managers (Merchant Bankers) for Amanta Healthcare IPO
The following are the lead managers (also known as Merchant Bankers) for Amanta Healthcare IPO:
Beeline Capital Advisors Pvt Ltd.
Amanta Healthcare IPO Registrar
The following is the Amanta Healthcare IPO registrar details:
A mainboard IPO entirely via fresh issue, raising approx ₹126 crore at ₹120–₹126 per share, to be listed on BSE & NSE.
When does the IPO open and close?
Opens on September 1, 2025, and closes on September 3, 2025, with anchor allocation on August 29, 2025.
What are the investor quotas?
Retail: ≤35%, QIB: ≤50%, NII: ≤15%
What’s the lot size and minimum investment?
119 shares minimum, amounting to ₹14,994
When is the allotment and listing?
Allotment: September 4, 2025; Refunds & Demat credit: September 5, 2025; Listing: September 8, 2025
How will funds be used?
For setting up SteriPort and SVP lines at Hariyala (₹70 cr + ₹30.13 cr), and general corporate purposes
Important Disclaimer: UnlistedKraft strive to provide the most up-to-date and accurate IPO details. However, details may change due to regulatory or market developments. Please verify key information before investing.
Author: Diwakar Singh
Diwakar Kumar Singh is a BFSI specialist and finance writer with over 7 years of hands-on experience in financial research, content creation, and analysis.
A Gold Medalist in MBA (Marketing) from IMT, he combines deep analytical skills with practical insights gained from evaluating companies, IPOs, unlisted shares, financial ratios, and investment opportunities. Diwakar has personally analysed hundreds of financial instruments and market scenarios, which he uses to break down complex topics into clear, actionable advice.
He has authored numerous in-depth finance articles, published multiple books internationally, and contributed to research publications. His work focuses on helping everyday investors and readers make better-informed financial decisions through well-researched, evidence-based explanations that are always grounded in real-world application rather than theory alone.